Patent details

EP2801583 Title: Genetically modified human natural killer cell lines

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2801583
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14171739.7
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
08/07/2005
Grant date:
25/04/2018
EP Publication Date:
12/11/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
11/07/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/04/2018
EP B1 Publication Date:
25/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
07/07/2025
Lapsed By Expiration Date:
08/07/2025
Patent Validated Date:
02/08/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
25/04/2018
 
 

 

Name:
Fox Chase Cancer Center
Address:
333 Cottman Avenue, Philadelphia, PA 19111-2497, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
01/08/2018
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

Name:
Campbell, Kerry S.
Address:
Wyncote, PA 19095, United States of America (US)

Priority

Priority Patent Number:
586581 P
Priority Date:
10/07/2004
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 39/395; A61K 49/00; C07K 14/735; C07K 16/28; C07K 16/32; G01N 33/50; C12N 5/0783; A61K 35/12; A61K 35/17;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
28/25
Publication date:
09/07/2025
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
33/18
Publication date:
08/08/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
18/18
Publication date:
25/04/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed

2

Issue number:
201901
Publication date:
02/01/2019
Description:
International Patent Classification Changed

3

Issue number:
201822
Publication date:
30/05/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:
201817
Publication date:
25/04/2018
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
19/07/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
01/08/2018 Outgoing Correspondence Letter no formal defects 1 PDF /2/4/1/4/6/0800264142/docs/ep14171739.7_1_220588l271.pdf
11/07/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /2/4/1/4/6/0800264142/docs/ep14171739.7_0_incomingcorrespondenceelectronic20180711121416015.pdf
11/07/2018 Claims First filed claims 1 PDF /2/4/1/4/6/0800264142/docs/ep14171739.7_2_claims20180711121415310.pdf